We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > antibodies

News List

Arsanis Granted Key Patents for ASN100 Covering Cross-Neutralizing S. aureus Toxin Antibodies biospace
March 15, 2018
Arsanis, Inc. today announced that the United States Patent and Trademark Office ("USPTO") issued U.S.
AC Immune finds new antibodies targeting neurodegenerative diseases pharmaceutical-technology
August 24, 2017
Swiss clinical stage biopharmaceutical company AC Immune has discovered new antibodies against two targets, Alpha-synuclein and TDP-43, in the pathogenesis of neurodegenerative diseases.
Cell-Penetrating antibodies to oncogenic RAS show anti-tumor activity pharmaasia
May 31, 2017
The technology is being further developed by Orum Therapeutics
BioInvent expands manufacturing facility with Mobius bioreactors from Merck cphi-online
April 24, 2017
Fully scalable system streamlines drug development and production.
XO1 Founding Management Team Re-Unite to Launch SuperX and Announce $11m Series A Funding With Medic firstwordpharma
February 10, 2017
SuperX Ltd, a biopharmaceutical company based in Cambridge, UK, announced today it has completed an $11m Series A investment led by Medicxi to develop antibodies with anticoagulant properties.
Immune Pharma Enters a Research Partnership contractpharma
January 25, 2017
Will develop mono- and bispecific antibodies against tumors

Previous page 1 2 3 4 5 6 Next page